LUNA - SB-421a-006 - Clinical Trial
What is the Purpose of this Study?
If you take part in this study, you will visit the clinic at least ten times over about twenty seven months. Most visits will last two days, but some may take three days if needed. You will be placed into one of two groups by chance. One group will receive the study medicine, and the other group will receive a sham injection, which looks like a real injection but has no medicine.
Retinitis Pigmentosa
Who Can Participate in the Study?
People can join this study if they are older than 8 years or are adults. Both eyes must show signs of a vision disease called retinitis pigmentosa. They cannot have had eye injections in the past.
What is Involved?
This study is testing a new medicine called ultevursen. It is designed to help people who have a vision disease called retinitis pigmentosa caused by a specific genetic change called a USH2A exon 13 mutation. Researchers want to learn if this medicine is safe and if it can help slow down or improve vision loss.
Study Details
